Lynnette C. Fallon - 21 May 2026 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
26 May 2026, 16:30:15 UTC
Prior SEC filing
21 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Danilo D'Alessandro, by Power of Attorney for Lynnette C. Fallon

Key filing fact

Lynnette C. Fallon filed Form 4 for ClearPoint Neuro, Inc. (CLPT) on 26 May 2026.

Key facts

  • This page summarizes Lynnette C. Fallon's Form 4 filing for ClearPoint Neuro, Inc. (CLPT).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 26 May 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 21 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001195654 Primary reporting owner

FALLON LYNNETTE C

Relationship
Director
Address
C/O CLEARPOINT NEURO, INC., 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH
Signature
/s/ Danilo D'Alessandro, by Power of Attorney for Lynnette C. Fallon
Signature date
26 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLPT transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+12,820
Change %
Price
$0.000000*
Shares after
12,820
Date
21 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,820
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.

Footnote F2

The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .